{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:18:04Z","timestamp":1790338684097,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T00:00:00Z","timestamp":1533772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"CAMS Initiative for Innovative Medicine","award":["2017-I2M-3-017"],"award-info":[{"award-number":["2017-I2M-3-017"]}]},{"name":"The Education Reform Projects of Peking Union Medical College","award":["2015zlgc0706"],"award-info":[{"award-number":["2015zlgc0706"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s10620-018-5230-1","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T06:41:16Z","timestamp":1533796876000},"page":"3074-3083","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Case\u2013Control Study of Inflammatory Bowel Disease Patients with and without Clostridium difficile Infection and Poor Outcomes in Patients Coinfected with C. difficile and Cytomegalovirus"],"prefix":"10.1007","volume":"63","author":[{"given":"Yue","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,9]]},"reference":[{"key":"5230_CR1","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","volume":"370","author":"SS Magill","year":"2014","unstructured":"Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014;370:1198\u20131208.","journal-title":"N Engl J Med"},{"key":"5230_CR2","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1111\/j.1572-0241.2007.01780.x","volume":"103","author":"GC Nguyen","year":"2008","unstructured":"Nguyen GC, Kaplan GG, Harris ML, Brant SR. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008;103:1443\u20131450.","journal-title":"Am J Gastroenterol"},{"key":"5230_CR3","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.gtc.2009.07.003","volume":"38","author":"AN Ananthakrishnan","year":"2009","unstructured":"Ananthakrishnan AN, Issa M, Binion DG. Clostridium difficile and inflammatory bowel disease. Gastroenterol Clin N Am. 2009;38:711\u2013728.","journal-title":"Gastroenterol Clin N Am"},{"key":"5230_CR4","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/ibd.21457","volume":"17","author":"AN Ananthakrishnan","year":"2011","unstructured":"Ananthakrishnan AN, McGinley EL, Saeian K, Binion DG. Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:976\u2013983.","journal-title":"Inflamm Bowel Dis"},{"key":"5230_CR5","doi-asserted-by":"publisher","first-page":"430-8.e2","DOI":"10.1053\/j.gastro.2017.04.044","volume":"153","author":"H Singh","year":"2017","unstructured":"Singh H, Nugent Z, Yu BN, Lix LM, Targownik LE, Bernstein CN. Higher incidence of Clostridium difficile Infection among individuals with inflammatory bowel disease. Gastroenterology. 2017;153:430-8.e2.","journal-title":"Gastroenterology"},{"key":"5230_CR6","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1056\/NEJMra1403772","volume":"372","author":"DA Leffler","year":"2015","unstructured":"Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med. 2015;372:1539\u20131548.","journal-title":"N Engl J Med"},{"key":"5230_CR7","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/ibd.22964","volume":"19","author":"AM Berg","year":"2013","unstructured":"Berg AM, Kelly CP, Farraye FA. Clostridium difficile infection in the inflammatory bowel disease patient. Inflamm Bowel Dis. 2013;19:194\u2013204.","journal-title":"Inflamm Bowel Dis"},{"key":"5230_CR8","doi-asserted-by":"publisher","first-page":"29791","DOI":"10.1038\/srep29791","volume":"6","author":"T Zhang","year":"2016","unstructured":"Zhang T, Lin QY, Fei JX, et al. Clostridium difficile infection worsen outcome of hospitalized patients with inflammatory bowel disease. Sci Rep. 2016;6:29791.","journal-title":"Sci Rep"},{"key":"5230_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/1751-2980.12461","volume":"18","author":"YB Gu","year":"2017","unstructured":"Gu YB, Zhang MC, Sun J, Lv KZ, Zhong J. Risk factors and clinical outcome of Clostridium difficile infection in patients with IBD: a single-center retrospective study of 260 cases in China. J Dig Dis. 2017;18:207\u2013211.","journal-title":"J Dig Dis"},{"key":"5230_CR10","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","volume":"2","author":"SC Truelove","year":"1955","unstructured":"Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955;2:1041\u20131048.","journal-title":"Br Med J"},{"key":"5230_CR11","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJM198712243172603","volume":"317","author":"KW Schroeder","year":"1987","unstructured":"Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317:1625\u20131629.","journal-title":"N Engl J Med"},{"key":"5230_CR12","doi-asserted-by":"publisher","first-page":"5a","DOI":"10.1155\/2005\/269076","volume":"19","author":"MS  Silverberg","year":"2005","unstructured":"Silverberg, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19:5a\u201336a.","journal-title":"Can J Gastroenterol"},{"key":"5230_CR13","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0140-6736(80)92767-1","volume":"1","author":"RF Harvey","year":"1980","unstructured":"Harvey RF, Bradshaw JM. A simple index of Crohn\u2019s-disease activity. Lancet (London, England). 1980;1:514.","journal-title":"Lancet (London, England)"},{"key":"5230_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1136\/gut.2007.128231","volume":"57","author":"AN Ananthakrishnan","year":"2008","unstructured":"Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut. 2008;57:205\u2013210.","journal-title":"Gut"},{"key":"5230_CR15","first-page":"345","volume":"5","author":"M Issa","year":"2007","unstructured":"Issa M, Vijayapal A, Graham MB, et al. Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2007;5:345\u2013351.","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"5230_CR16","first-page":"339","volume":"5","author":"JF Rodemann","year":"2007","unstructured":"Rodemann JF, Dubberke ER, Reske KA, Seo DH, Stone CD. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2007;5:339\u2013344.","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"5230_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/ecco-jcc\/jjw117","volume":"11","author":"NM Joshi","year":"2017","unstructured":"Joshi NM, Marks IH, Crowson R, Ball D, Rampton DS. Incidence and outcome of Clostridium difficile infection in hospitalized patients with inflammatory bowel disease in the UK. J Crohn\u2019s Colitis. 2017;11:70\u201376.","journal-title":"J Crohn\u2019s Colitis"},{"key":"5230_CR18","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2036.2010.04548.x","volume":"33","author":"JR Goodhand","year":"2011","unstructured":"Goodhand JR, Alazawi W, Rampton DS. Systematic review: Clostridium difficile and inflammatory bowel disease. Aliment Pharmacol Ther. 2011;33:428\u2013441.","journal-title":"Aliment Pharmacol Ther"},{"key":"5230_CR19","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.crohns.2009.11.001","volume":"4","author":"S Ben-Horin","year":"2010","unstructured":"Ben-Horin S, Margalit M, Bossuyt P, et al. Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection. J Crohn\u2019s Colitis. 2010;4:194\u2013198.","journal-title":"J Crohn\u2019s Colitis"},{"key":"5230_CR20","doi-asserted-by":"publisher","first-page":"5338","DOI":"10.1128\/JCM.43.10.5338-5340.2005","volume":"43","author":"RJ Berg van den","year":"2005","unstructured":"van den Berg RJ, Bruijnesteijn van Coppenraet LS, Gerritsen HJ, Endtz HP, van der Vorm ER, Kuijper EJ. Prospective multicenter evaluation of a new immunoassay and real-time PCR for rapid diagnosis of Clostridium difficile-associated diarrhea in hospitalized patients. J Clin Microbiol. 2005;43:5338\u20135340.","journal-title":"J Clin Microbiol"},{"key":"5230_CR21","first-page":"36","volume":"56","author":"RJ Berg van den","year":"2007","unstructured":"van den Berg RJ, Vaessen N, Endtz HP, Schulin T, van der Vorm ER, Kuijper EJ. Evaluation of real-time PCR and conventional diagnostic methods for the detection of Clostridium difficile-associated diarrhoea in a prospective multicentre study. J Clin Microbiol. 2007;56:36\u201342.","journal-title":"J Clin Microbiol"},{"key":"5230_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1365-2036.2009.04037.x","volume":"30","author":"S Schneeweiss","year":"2009","unstructured":"Schneeweiss S, Korzenik J, Solomon DH, Canning C, Lee J, Bressler B. Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections. Aliment Pharmacol Ther. 2009;30:253\u2013264.","journal-title":"Aliment Pharmacol Ther"},{"key":"5230_CR23","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1111\/apt.12706","volume":"39","author":"AN Ananthakrishnan","year":"2014","unstructured":"Ananthakrishnan AN, Cagan A, Gainer VS, et al. Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases. Aliment Pharmacol Ther. 2014;39:1136\u20131142.","journal-title":"Aliment Pharmacol Ther"},{"key":"5230_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cellimm.2012.11.009","volume":"280","author":"D Vandamme","year":"2012","unstructured":"Vandamme D, Landuyt B, Luyten W, Schoofs L. A comprehensive summary of LL-37, the factotum human cathelicidin peptide. Cell Immunol. 2012;280:22\u201335.","journal-title":"Cell Immunol"},{"key":"5230_CR25","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1136\/gutjnl-2012-302180","volume":"62","author":"TC Hing","year":"2013","unstructured":"Hing TC, Ho S, Shih DQ, et al. The antimicrobial peptide cathelicidin modulates Clostridium difficile-associated colitis and toxin A-mediated enteritis in mice. Gut. 2013;62:1295\u20131305.","journal-title":"Gut"},{"key":"5230_CR26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.crohns.2010.09.007","volume":"5","author":"R Kariv","year":"2011","unstructured":"Kariv R, Navaneethan U, Venkatesh PG, Lopez R, Shen B. Impact of Clostridium difficile infection in patients with ulcerative colitis. J Crohn\u2019s Colitis. 2011;5:34\u201340.","journal-title":"J Crohn\u2019s Colitis"},{"key":"5230_CR27","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1097\/MIB.0000000000000939","volume":"22","author":"JD McCurdy","year":"2016","unstructured":"McCurdy JD, Enders FT, Khanna S, et al. Increased rates of Clostridium difficile infection and poor outcomes in patients with IBD with cytomegalovirus. Inflamm Bowel Dis. 2016;22:2688\u20132693.","journal-title":"Inflamm Bowel Dis"},{"key":"5230_CR28","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jmii.2015.12.007","volume":"49","author":"KS Chan","year":"2016","unstructured":"Chan KS, Lee WY, Yu WL. Coexisting cytomegalovirus infection in immunocompetent patients with Clostridium difficile colitis. J Microbiol Immunol Infect. 2016;49:829\u2013836.","journal-title":"J Microbiol Immunol Infect"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-018-5230-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-5230-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-018-5230-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T19:20:40Z","timestamp":1565292040000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-018-5230-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,9]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["5230"],"URL":"https:\/\/doi.org\/10.1007\/s10620-018-5230-1","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,9]]},"assertion":[{"value":"4 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have no conflicts of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}